Active substance
Flunisolide
- US FDA 8
- US price lines 1
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| FLUNISOLIDE | 0.025MG/SPRAY | spray, metered · nasal | BAUSCH | Prescription | 20 Feb 2002 |
| FLUNISOLIDE | 0.025MG/SPRAY | spray, metered · nasal | RISING | Prescription | 3 Aug 2006 |
| FLUNISOLIDE | 0.025MG/SPRAY | spray, metered · nasal | RICONPHARMA LLC | Prescription | 16 Jun 2022 |
| NASALIDE | 0.025MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | spray, metered · nasal | IVAX RES | Discontinued | 24 Sep 1981 |
| AEROBID | 0.25MG/INH | aerosol, metered · inhalation | ROCHE PALO | Discontinued | 17 Aug 1984 |
| NASAREL | 0.029MG/SPRAY | spray, metered · nasal | TEVA BRANDED PHARM | Discontinued | 8 Mar 1995 |
| AEROSPAN HFA | 0.078MG/INH | aerosol, metered · inhalation | PHARMOBEDIENT | Discontinued | 27 Jan 2006 |
| FLUNISOLIDE | 0.029MG/SPRAY | spray, metered · nasal | APOTEX | Discontinued | 9 Aug 2007 |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | FLUNISOLIDE 0.025% SPRAY | $1.98777 | per ML | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 25 Apr 2018 AEROSPAN HFA — safety-related labeling change
Labeling sections changed: Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.